9 completed, 3 recruiting, 2 terminated, 2 unknown. 7 Not applicable, 5 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 5, Recruiting 1, Unknown 1 |
| Phase 3 | 5 | Completed 3, Terminated 2 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Paroxysmal Supraventricular Tachycardia: new trials by email Literature Review of Paroxysmal Supraventricular Tachycardia trials Research Report on Paroxysmal Supraventricular Tachycardia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NASVAL-SVT: Nasal Swab Versus Modified Valsalva for Supraventricular Tachycardia Nasopharyngeal Swab Insertion, Modified Valsalva Maneuver (REVERT Protocol) - Supraventricular Tachycardia, Paroxysmal Supraventricular Tachycardia | Not applicable | Recruiting | Marmara University Pendik Training and Research Hospital | 60 | 2026-05-01 | 2026-06-01 |
| MCG for Localization of Tachyarrhythmia's Origin Magnetocardiography - Tachyarrhythmia, Atrial Flutter | Not applicable | Unknown | Qilu Hospital of Shandong University | 1000 | 2024-03-14 | 2024-08-21 |
| The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) Etripamil NS - Paroxysmal Supraventricular Tachycardia | Phase 2 | Recruiting | Milestone Pharmaceuticals Inc. | 60 | 2023-12-11 | 2026-07-21 |
| AI-Based Differential Diagnosis and Localization of Tachycardia Using ECG: Multicenter Registry (EP-AI ASSIST) AI-based ECG Diagnostic and Localization Algorithm - Tachycardia, Paroxysmal Supraventricular Tachycardia | Recruiting | Inha University Hospital | 10000 | 2023-12-01 | 2026-10-05 | |
| A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia Pulsed Field Ablation Device and CF-Sensing Pulsed Field Ablation Catheter - Paroxysmal Supraventricular Tachycardia, Atrioventricular Nodal Reentrant Tachycardia | Not applicable | Completed | Shanghai MicroPort EP MedTech Co., Ltd. | 164 | 2023-03-09 | 2025-05-28 |
| Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study Focal Pulsed Field Ablation (PFA), Focal Radiofrequecy Ablation (RFA) - Paroxysmal Supraventricular Tachycardia, Catheter Ablation | Unknown | Caijie Shen | 428 | 2022-10-11 | 2024-10-24 | |
| Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia（PSVT） Pulsed Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter - Paroxysmal Supraventricular Tachycardia | Not applicable | Completed | Ningbo No. 1 Hospital | 10 | 2022-10-11 | 2024-01-03 |
| Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia Etripamil NS 70 mg, Placebo - Tachycardia, Supraventricular, Paroxysmal Supraventricular Tachycardia | Phase 3 | Completed | Corxel Pharmaceuticals | 500 | 2022-06-30 | 2026-10-22 |
| Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia Etripamil NS 70 mg, Aptar Pharma Nasal Spray Bidose System - Paroxysmal Supraventricular Tachycardia | Phase 3 | Completed | Milestone Pharmaceuticals Inc. | 130 | 2021-12-13 | 2026-05-15 |
| Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes Microfidelity (MIFI) catheter, Conventional ablation catheter - Paroxysmal Supraventricular Tachycardia | Not applicable | Completed | Yong Seog Oh | 136 | 2020-01-13 | 2021-11-02 |
| Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 Etripamil NS - Paroxysmal Supraventricular Tachycardia | Phase 3 | Completed | Milestone Pharmaceuticals Inc. | 1116 | 2019-09-23 | 2024-05-23 |
| Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 Etripamil NS 70 mg, Aptar Pharma Nasal Spray Bidose System - Paroxysmal Supraventricular Tachycardia | Phase 3 | Terminated | Milestone Pharmaceuticals Inc. | 169 | 2018-12-10 | 2024-11-05 |
| Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). Etripamil, Placebo, Etripamil Test Dose - Paroxysmal Supraventricular Tachycardia | Phase 3 | Terminated | Milestone Pharmaceuticals Inc. | 1097 | 2018-06-18 | 2024-07-12 |
| Study on Left Atrial Function of Paroxysmal Supraventricular Tachycardia After Radiofrequency Ablation radiofrequency ablation - Paroxysmal Supraventricular Tachycardia | Not applicable | Completed | Ruiqin xie | 100 | 2017-01-01 | 2020-03-18 |
| Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia Zero-fluoroscopic ablation, Conventional fluoroscopic ablation - Paroxysmal Supraventricular Tachycardia | Not applicable | Completed | Tongji Hospital | 3060 | 2012-01-01 | 2023-11-24 |
| Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control Verapamil - Paroxysmal Supraventricular Tachycardia | Phase 4 | Completed | Tehran University of Medical Sciences | 90 | 2010-10-01 | 2012-11-14 |
Tachycardia, Ventricular (16) · Tachycardia, Atrioventricular Nodal Reentry (4) · Tachycardia (2) · Tachycardia, Supraventricular (2) · Ventricular Premature Complexes (2) · Atrial Fibrillation (1) · Atrial Flutter (1) · Emergencies (1) · Wolff-Parkinson-White Syndrome (1)
Arrhythmias, Cardiac (16) · Cardiac Conduction System Disease (16) · Cardiovascular Diseases (16) · Heart Diseases (16) · Pathologic Processes (16) · Pathological Conditions, Signs and Symptoms (16) · Tachycardia (14) · Tachycardia, Reciprocating (4) · Cardiac Complexes, Premature (2) · Cardiovascular Abnormalities (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Heart Defects, Congenital (1) · Pre-Excitation Syndromes (1)
Catheters (1) · Magnetocardiography (1) · Radiofrequency Ablation (1) · Verapamil (1) · etripamil (1)
Milestone Pharmaceuticals Inc. (5) · Caijie Shen (1) · Corxel Pharmaceuticals (1) · Inha University Hospital (1) · Marmara University Pendik Training and Research Hospital (1) · Ningbo No. 1 Hospital (1) · Qilu Hospital of Shandong University (1) · Ruiqin xie (1) · Shanghai MicroPort EP MedTech Co., Ltd. (1) · Tehran University of Medical Sciences (1) · Tongji Hospital (1) · Yong Seog Oh (1)
China (7) · Canada (5) · United States (5) · Germany (2) · South Korea (2) · Spain (2) · Argentina (1) · Belgium (1) · Brazil (1) · Colombia (1) · France (1) · Hungary (1) · Netherlands (1) · Poland (1) · Turkey (Türkiye) (1)
David Bharucha, MD (2) · Caijie Shen (1) · Changsheng Ma (1) · Francis Plat, MD (1) · Xiaowen Chen (1) · Yan Wang, PhD (1) · Yong-Seog Oh (1) · Yuguo Chen, Professor (1)
PMID 14994602, PMID 26314489, PMID 32013865, PMID 33360757, PMID 33914064, PMID 35728658, PMID 35924472, PMID 36441560, PMID 37169581, PMID 37331368, PMID 37543444, PMID 37753718, PMID 38242530, PMID 40187990, PMID 40931676, PMID 41668514
2018 (1)